Injection site reactions (redness, swelling, itching) are common adverse effects, typically mild and self-limiting
Jump to: What the study found | Why the same medication works differently | The variant linked to weight loss | The variant linked to nausea on Mounjaro | The 23andMe consumer report | Limitations to keep in mind | What this means for the UK | Take home message Two people can take the same GLP-1 medication at the same dose and have very different experiences
Heres what early studies have shown: Pancreatitis: Reported in about 0.4% Gallbladder problems: Seen in about 1.1% , with no cases in the placebo group Heart rhythm changes: Reported more often with retatrutide ( about 6% vs 3% with placebo ) Liver enzyme increases: Rare (around 1% ), with overall liver health markers staying stable While these serious side effects were uncommon, theyre still important to keep in mind
Rada P, Rojo AI, Chowdhry S, McMahon M, Hayes JD, Cuadrado A
Available as a pre-blended vial or mixed individually